Literature DB >> 9210052

Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases.

C Daumas-Duport1, P Varlet, M L Tucker, F Beuvon, P Cervera, J P Chodkiewicz.   

Abstract

The present study has attempted to demonstrate that the morphological spectrum of oligodendrogliomas includes tumors which are traditionally misinterpreted as 'diffuse fibrillary astrocytoma'. We have shown that these tumors are in fact made of isolated neoplastic oligodendrocytes which are entrapped in a fibrillary background composed of axons and fibrillary reactive gliosis. Analysis in a series of 153 'pure' supratentorial oligodendrogliomas composed of 'classical' or pseudo 'diffuse fibrillary oligodendrogliomas' diagnosed by imaging-based serial stereotactic biopsies showed that 2/3 of the tumors were exclusively made of isolated tumor cells (ITCs) (structure type III) and that only 1/3 of them exhibited both ITCs and solid tumor tissue components (structure type II). The tumor tissue destroys the brain parenchyma and contains new formed microblood vessels whereas ITCs do not destroy the parenchyma and are not associated with microangiogenesis. These fundamentally opposite morphological characteristics were reflected by the following findings: 1) contrast enhancement was observed in 64% of structure type II but was never seen in structure type III oligodendrogliomas. 2) a neurological deficit occurred in 57% of structure type II but in only 8% of structure type III oligodendrogliomas. 3) using the new grading system described in the companion paper to this study, we found that the biological behavior of oligodendrogliomas was also closely related to the patterns of tumor growth. From a synthesis of data gathered in this study it is suggested that emergence of microangiogenesis within a tumor which at first grows slowly with a structure type III pattern is a crucial event toward more aggressive behavior.

Entities:  

Mesh:

Year:  1997        PMID: 9210052     DOI: 10.1023/a:1005707203596

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

1.  Oligodendroglioma. A comparison of two grading systems.

Authors:  J M Kros; D Troost; C G van Eden; A J van der Werf; H B Uylings
Journal:  Cancer       Date:  1988-06-01       Impact factor: 6.860

2.  The role of postoperative irradiation in the treatment of oligodendroglioma.

Authors:  D E Gannett; W M Wisbeck; D L Silbergeld; M S Berger
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-10-15       Impact factor: 7.038

Review 3.  Histoprognosis of gliomas.

Authors:  C Daumas-Duport
Journal:  Adv Tech Stand Neurosurg       Date:  1994

4.  Pediatric and adolescent oligodendrogliomas.

Authors:  H Tice; P D Barnes; L Goumnerova; R M Scott; N J Tarbell
Journal:  AJNR Am J Neuroradiol       Date:  1993 Nov-Dec       Impact factor: 3.825

5.  Oligodendroglioma: an analysis of 42 cases.

Authors:  I M Wilkinson; J R Anderson; A E Holmes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-03       Impact factor: 10.154

6.  Serial stereotactic biopsies and CT scan in gliomas: correlative study in 100 astrocytomas, oligo-astrocytomas and oligodendrocytomas.

Authors:  C Daumas-Duport; V Monsaigneon; S Blond; C Munari; A Musolino; J P Chodkiewicz; O Missir
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

7.  Oligodendrogliomas. I. A clinical study of cerebral oligodendrogliomas.

Authors:  H W Chin; J J Hazel; T H Kim; J H Webster
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

8.  Oligodendrogliomas: the Mayo Clinic experience.

Authors:  E G Shaw; B W Scheithauer; J R O'Fallon; H D Tazelaar; D H Davis
Journal:  J Neurosurg       Date:  1992-03       Impact factor: 5.115

9.  Oligodendroglioma. An analysis of the value of radiation therapy.

Authors:  D E Bullard; C E Rawlings; B Phillips; E B Cox; S C Schold; P Burger; E C Halperin
Journal:  Cancer       Date:  1987-11-01       Impact factor: 6.860

10.  Cerebral oligodendroglioma: prognostic factors and life history.

Authors:  P Celli; I Nofrone; L Palma; G Cantore; A Fortuna
Journal:  Neurosurgery       Date:  1994-12       Impact factor: 4.654

View more
  60 in total

1.  Extensive intra-tumor heterogeneity in primary human glial tumors as a result of locus non-specific genomic alterations.

Authors:  A Misra; P Chattopadhyay; A K Dinda; C Sarkar; A K Mahapatra; S E Hasnain; S Sinha
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendroglioma. An analysis of 91 cases.

Authors:  A Korshunov; A Golanov
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

3.  Improving the time-machine: estimating date of birth of grade II gliomas.

Authors:  C Gerin; J Pallud; B Grammaticos; E Mandonnet; C Deroulers; P Varlet; L Capelle; L Taillandier; L Bauchet; H Duffau; M Badoual
Journal:  Cell Prolif       Date:  2011-12-14       Impact factor: 6.831

4.  Extradural cord compression due to metastatic oligodendroglioma.

Authors:  Jeff Garner; Yehya Morcos; Mohammed Bari
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

5.  Dynamic imaging response following radiation therapy predicts long-term outcomes for diffuse low-grade gliomas.

Authors:  Johan Pallud; Jean-François Llitjos; Frédéric Dhermain; Pascale Varlet; Edouard Dezamis; Bertrand Devaux; Raphaëlle Souillard-Scémama; Nader Sanai; Maria Koziak; Philippe Page; Michel Schlienger; Catherine Daumas-Duport; Jean-François Meder; Catherine Oppenheim; François-Xavier Roux
Journal:  Neuro Oncol       Date:  2012-03-13       Impact factor: 12.300

6.  Unique patterns of diffusion directionality in rat brain tumors revealed by high-resolution diffusion tensor MRI.

Authors:  Jiangyang Zhang; Peter C M van Zijl; John Laterra; Amandeep Salhotra; Bachchu Lal; Susumu Mori; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2007-09       Impact factor: 4.668

7.  Histological and MR correlations in Gliomatosis cerebri.

Authors:  Paule Peretti-Viton; Hervé Brunel; Olivier Chinot; Clément Daniel; Maryline Barrié; Corinne Bouvier; Dominique Figarella-Branger; Stéphane Fuentes; Henry Dufour; François Grisoli
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

8.  Salvage chemotherapy with CPT-11 for recurrent oligodendrogliomas.

Authors:  Marc C Chamberlain
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

9.  High and low grade oligodendrogliomas (ODG): correlation of amino-acid and glucose uptakes using PET and histological classifications.

Authors:  F Giammarile; L E Cinotti; A Jouvet; J M Ramackers; G Saint Pierre; P Thiesse; E Jouanneau; J Guyotat; I Pelissou-Guyotat; A Setiey; J Honnorat; D Le Bars; D Frappaz
Journal:  J Neurooncol       Date:  2004-07       Impact factor: 4.130

10.  Loss of heterozygosity for loci on chromosome arms 1p and 10q in oligodendroglial tumors: relationship to outcome and chemosensitivity.

Authors:  Brian Thiessen; John A Maguire; Kelly McNeil; David Huntsman; Montgomery A Martin; Doug Horsman
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.